What is Cardiac Ablation Devices?

 

Cardiac Ablation Devices Market By Technology (Radiofrequency (RF) Ablation, Electrical Ablation, Cryoablation, Ultrasound Ablation, Microwave Ablation), By Product (Radiofrequency (RF) Ablators [Temperature-Controlled Radiofrequency Ablators, Fluid-Cooled Radiofrequency Ablators, Robotic Catheter Manipulation Systems], Electrical Ablators [Argon Plasma/Beam Coagulators, Irreversible Electroporation Systems], Cryoablation Devices [Tissue Contact Probes, Others], Ultrasound Ablators [High-Intensity Focused Ultrasound Ablators, Ultrasound Ablation Systems, Others], Microwave Ablators [Microwave Thermotherapy Devices]), By Application (Cardiac Rhythm Management, Open Surgery, Others), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), by geography is expected to grow at a steady CAGR forecast till 2026 owing to growth in new therapies and increasing prevalence of cardiovascular diseases. 

Global Cardiac Ablation Devices Market was valued at USD 2.00 billion in 2020, growing at a CAGR of 12.78% during the forecast period from 2021 to 2026, to reach USD 4.12 billion by 2026. The demand for Cardiac Ablation Devices is motivated by a rise in the prevalence of cardiovascular diseases like cardiac arrhythmia, atrial fibrillation, and stroke. Further, growth in new therapies, technological advancements, increasing geriatric population, and penetration and acceptance of Cardiac Ablation Devices in emerging countries will drive the market growth. Cardiac Ablation Devices were found to be extremely beneficial in heart failure cases in COVID-19 which further pushed for the demand for these devices in the pandemic situation